AMRN
Price
$15.91
Change
-$0.44 (-2.69%)
Updated
Jun 26 closing price
Capitalization
335.19M
Intraday BUY SELL Signals
WHWK
Price
$4.16
Change
+$0.05 (+1.22%)
Updated
Jun 26 closing price
Capitalization
206.22M
46 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

AMRN vs WHWK

AMRN vs WHWK Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
AMRN vs. WHWK commentary
Jun 27, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AMRN is a Hold and WHWK is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 27, 2026
Stock price -- (AMRN: $15.98 vs. WHWK: $4.17)
Brand notoriety: AMRN: Notable vs. WHWK: Not notable
AMRN represents the Pharmaceuticals: Major, while WHWK is part of the Biotechnology industry
Current volume relative to the 65-day Moving Average: AMRN: 88% vs. WHWK: 857%
Market capitalization -- AMRN: $335.19M vs. WHWK: $206.22M
AMRN [@Pharmaceuticals: Major] is valued at $335.19M. WHWK’s [@Biotechnology] market capitalization is $206.22M. The market cap for tickers in the [@Pharmaceuticals: Major] industry ranges from $1.08T to $0. The market cap for tickers in the [@Biotechnology] industry ranges from $124.7B to $0. The average market capitalization across the [@Pharmaceuticals: Major] industry is $195.56B. The average market capitalization across the [@Biotechnology] industry is $2.06B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AMRN’s FA Score shows that 0 FA rating(s) are green whileWHWK’s FA Score has 0 green FA rating(s).

  • AMRN’s FA Score: 0 green, 5 red.
  • WHWK’s FA Score: 0 green, 5 red.
According to our system of comparison, WHWK is a better buy in the long-term than AMRN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AMRN’s TA Score shows that 5 TA indicator(s) are bullish while WHWK’s TA Score has 4 bullish TA indicator(s).

  • AMRN’s TA Score: 5 bullish, 5 bearish.
  • WHWK’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, both AMRN and WHWK are a good buy in the short-term.

Price Growth

AMRN (@Pharmaceuticals: Major) experienced а -0.28% price change this week, while WHWK (@Biotechnology) price change was -5.66% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Major industry was +5.39%. For the same industry, the average monthly price growth was +13.43%, and the average quarterly price growth was +8.67%.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.08%. For the same industry, the average monthly price growth was +1.67%, and the average quarterly price growth was +1916.03%.

Reported Earning Dates

WHWK is expected to report earnings on Aug 12, 2026.

Industries' Descriptions

@Pharmaceuticals: Major (+5.39% weekly)

The Major Pharmaceuticals industry includes companies that are involved in various processes of creating drugs to treat/prevent diseases. These companies engage in research, testing and manufacturing, as well as the distribution of pharmaceuticals into markets. Johnson & Johnson, Merck & Co., Inc., Pfizer Inc. and Novartis are among the largest companies in this category.

@Biotechnology (+4.08% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
AMRN($335M) has a higher market cap than WHWK($206M). WHWK YTD gains are higher at: 72.314 vs. AMRN (14.547). AMRN has higher annual earnings (EBITDA): -24.36M vs. WHWK (-28.88M). AMRN has more cash in the bank: 308M vs. WHWK (123M). WHWK has less debt than AMRN: WHWK (0) vs AMRN (5.59M). AMRN has higher revenues than WHWK: AMRN (217M) vs WHWK (0).
AMRNWHWKAMRN / WHWK
Capitalization335M206M163%
EBITDA-24.36M-28.88M84%
Gain YTD14.54772.31420%
P/E RatioN/A11.67-
Revenue217M0-
Total Cash308M123M250%
Total Debt5.59M0-
FUNDAMENTALS RATINGS
AMRN vs WHWK: Fundamental Ratings
AMRN
WHWK
OUTLOOK RATING
1..100
1742
VALUATION
overvalued / fair valued / undervalued
1..100
83
Overvalued
65
Fair valued
PROFIT vs RISK RATING
1..100
10093
SMR RATING
1..100
9499
PRICE GROWTH RATING
1..100
4540
P/E GROWTH RATING
1..100
10049
SEASONALITY SCORE
1..100
5085

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

WHWK's Valuation (65) in the Pharmaceuticals Major industry is in the same range as AMRN (83) in the Pharmaceuticals Other industry. This means that WHWK’s stock grew similarly to AMRN’s over the last 12 months.

WHWK's Profit vs Risk Rating (93) in the Pharmaceuticals Major industry is in the same range as AMRN (100) in the Pharmaceuticals Other industry. This means that WHWK’s stock grew similarly to AMRN’s over the last 12 months.

AMRN's SMR Rating (94) in the Pharmaceuticals Other industry is in the same range as WHWK (99) in the Pharmaceuticals Major industry. This means that AMRN’s stock grew similarly to WHWK’s over the last 12 months.

WHWK's Price Growth Rating (40) in the Pharmaceuticals Major industry is in the same range as AMRN (45) in the Pharmaceuticals Other industry. This means that WHWK’s stock grew similarly to AMRN’s over the last 12 months.

WHWK's P/E Growth Rating (49) in the Pharmaceuticals Major industry is somewhat better than the same rating for AMRN (100) in the Pharmaceuticals Other industry. This means that WHWK’s stock grew somewhat faster than AMRN’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
AMRNWHWK
RSI
ODDS (%)
Bearish Trend 1 day ago
86%
N/A
Stochastic
ODDS (%)
Bearish Trend 1 day ago
88%
Bullish Trend 1 day ago
85%
Momentum
ODDS (%)
Bullish Trend 1 day ago
76%
Bullish Trend 1 day ago
84%
MACD
ODDS (%)
Bullish Trend 1 day ago
77%
Bearish Trend 1 day ago
78%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
87%
Bearish Trend 1 day ago
78%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
75%
Bearish Trend 1 day ago
81%
Advances
ODDS (%)
Bullish Trend 3 days ago
74%
Bullish Trend 5 days ago
79%
Declines
ODDS (%)
Bearish Trend 1 day ago
86%
Bearish Trend 19 days ago
81%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
85%
N/A
Aroon
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 5 days ago
85%
View a ticker or compare two or three
Interact to see
Advertisement
AMRN
Daily Signal:
Gain/Loss:
WHWK
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
JENSX42.10N/A
N/A
Jensen Quality Growth J
IGMIX9.84N/A
N/A
Voya Global Insights Portfolio I
VEVIX50.80N/A
N/A
Victory Sycamore Established Value I
GLNBX22.21N/A
N/A
MFS Global New Discovery B
GCPCX22.81N/A
N/A
Gateway Equity Call Premium C

WHWK and

Correlation & Price change

A.I.dvisor indicates that over the last year, WHWK has been loosely correlated with AXON. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if WHWK jumps, then AXON could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To WHWK
1D Price
Change %
WHWK100%
+1.46%
AXON - WHWK
44%
Loosely correlated
+4.52%
AMRN - WHWK
37%
Loosely correlated
-2.23%
ARRY - WHWK
36%
Loosely correlated
-7.41%
PRQR - WHWK
36%
Loosely correlated
-2.24%
NGNE - WHWK
34%
Loosely correlated
+5.39%
More